Stock Events

Stock Events

SOPHiA Genetics SA 

$7.64
20
+$0.01+0.13% 19:49 Today

Statistics

Day High
7.86
Day Low
7.52
52W High
7.88
52W Low
3.1
Volume
390,339
Avg. Volume
314,880
Mkt Cap
640.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.33
-0.29
-0.24
-0.2
Expected EPS
-0.198
Actual EPS
N/A

Financials

-102.24%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
77.27MRevenue
-79MNet Income

Analyst Ratings

11.50Average Price Target
The highest estimate is 14.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SOPH. It's not an investment recommendation.
SoundHound AI
4
SOUN
Joby Aviation
4
JOBY
Microsoft
3
MSFT
NVIDIA
3
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap28.82B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with SOPHiA Genetics' data-driven analysis.
Pacific Biosciences of California
PACB
Mkt Cap357.46M
Pacific Biosciences offers long-read sequencing technologies that compete with SOPHiA Genetics in the genomic analysis and clinical diagnostics market.
Guardant Health
GH
Mkt Cap21.1B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with SOPHiA Genetics in the oncology diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap510.68M
Fulgent Genetics offers comprehensive genetic testing and competes with SOPHiA Genetics in the genetic analysis and diagnostics market.
Qiagen NV
QGEN
Mkt Cap8.87B
Bionano Genomics
BNGO
Mkt Cap13.9M
Bionano Genomics focuses on genomic analysis with its Saphyr system, competing in the structural variation analysis market alongside SOPHiA Genetics.
Thermo Fisher Scientific
TMO
Mkt Cap217.52B
Thermo Fisher Scientific offers a wide range of solutions for genetic analysis and diagnostics, making it a broad competitor to SOPHiA Genetics in the life sciences sector.
Intellia Therapeutics
NTLA
Mkt Cap1.67B
Intellia Therapeutics is involved in CRISPR gene editing, a technology that could compete with SOPHiA Genetics in the future of genetic diagnostics and therapeutics.

About

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Show more...
CEO
Ross Muken
Employees
415
Country
Switzerland
ISIN
CH1125843347
WKN
000A3CVT8

Listings

STU
DE
90B.STU
F
DE
90B.F
XNAS
US
SOPH
BOATS
BOATS
SOPH.BOATS

0 Comments

Share your thoughts

FAQ

What is SOPHiA Genetics SA stock price today?▼
The current price of SOPH is $7.64 USD — it has increased by +0.13% in the past 24 hours. Watch SOPHiA Genetics SA stock price performance more closely on the chart.
What is SOPHiA Genetics SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange SOPHiA Genetics SA stocks are traded under the ticker SOPH.
Is SOPHiA Genetics SA stock price growing?▼
SOPH stock has risen by +0.79% compared to the previous week, the month change is a +30.66% rise, over the last year SOPHiA Genetics SA has showed a +119.77% increase.
What is SOPHiA Genetics SA market cap?▼
Today SOPHiA Genetics SA has the market capitalization of 640.96M
When is the next SOPHiA Genetics SA earnings date?▼
SOPHiA Genetics SA is going to release the next earnings report on November 10, 2026.
What were SOPHiA Genetics SA earnings last quarter?▼
SOPH earnings for the last quarter are -0.3 USD per share, whereas the estimation was -0.21 USD resulting in a -42.83% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SOPHiA Genetics SA revenue for the last year?▼
SOPHiA Genetics SA revenue for the last year amounts to 77.27M USD.
What is SOPHiA Genetics SA net income for the last year?▼
SOPH net income for the last year is -79M USD.
How many employees does SOPHiA Genetics SA have?▼
As of August 18, 2026, the company has 415 employees.
In which sector is SOPHiA Genetics SA located?▼
SOPHiA Genetics SA operates in the Health & Wellness sector.
When did SOPHiA Genetics SA complete a stock split?▼
SOPHiA Genetics SA has not had any recent stock splits.
Where is SOPHiA Genetics SA headquartered?▼
SOPHiA Genetics SA is headquartered in Rolle, Switzerland.